Phase
Condition
Weight Loss
Treatment
Western Diet
CLEAN-MED
Clinical Study ID
Ages 18-60 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
In order to be eligible to participate in this study, an individual must meet all of the following criteria:
Ability of subject to understand and the willingness to sign a written informedconsent document
Age 18-60, at the time of consent
Willingness to adhere to the dietary regimen and report any major stressors thatoccur during the study (i.e. changing jobs, moving, death of a closerelative/friend, etc.)
Willingness to provide blood and stool specimens as specified
BMI >=18 and <= 35 kg/m^2
Access to necessary resources for participating in a technology-based intervention:computer, smartphone, internet access, etc.
Has the ability/transportation methods to attend on-site visits
For 50 of the 60 participants in short-term cohort and for 40 of the 50 participantsin the long-term cohort: Currently following a Western diet with PREDIMED-17 MedDietscore <= 7 for >= 1 months and a CLEAN-MED NOVA score of >= 35% kcal in NOVA 4category with >= 14 items/week in NOVA 4
For 10 of the 60 participants in short-term cohort and for 10 of the 50 participantsin the long-term cohort: Currently following a Western diet with PREDIMED-17 MedDietscore <= 10 for >= 1 months and a CLEAN-MED NOVA score of >= 20% kcal in NOVA 4category with >= 7 items/week in NOVA 4
CLEAN-MED Logging Score of >= 43 after initial trial week to continue in the studyfor the randomization step
For long-term cohort only: Have resources and capability to consume freshly-cooked (i.e. not pre-packaged or frozen) meals
Exclusion
EXCLUSION CRITERIA:
An individual who meets any of the following criteria will be excluded from participation in this study, at the discretion of the PI:
Current use of medications or dietary supplements for weight or appetite control,whether prescribed or not, including laxatives (within the last 4 weeks)
Currently eating a vegan, vegetarian, keto or other restrictive diet plan, or foodallergies that would affect eating the study diet, at the discretion of the PI
Active cardiovascular disease (in past year with myocardial infarction, coronarystent or bypass surgery)
Diabetes (type 1 and 2) or history of gestational diabetes or on hypoglycemicmedications or any other indication
Kidney disease (eGFR less than 50 mL/min per 1.73 m^2)
Liver disease (liver transaminase higher than 3 times the normal range for thelaboratory)
Symptomatic gallstones
History of active cancer in the past 3 years except for squamous or basal cellcarcinomas of the skin that have been medically managed by local excision
Has a diagnosed autoimmune condition (i.e. HIV, lupus, etc.) or otherimmunosuppressive or immunodeficient state, at the discretion of the PI
Musculoskeletal disorders precluding regular physical activity
Consumption of the following drugs: proton pump inhibitors, antidiabetic drugs,cholesterol lowering drugs, SGLT-2 inhibitors, GLP-1 receptor agonist, insulin,Amylin analog, Alpha-glucosidase inhibitor, Dopamine agonist, Bile acid sequestrant,corticosteroids, methotrexate or immunosuppressive cytotoxic agents
Some types of abdominal surgery, including bariatric surgery, or severe intestinalproblems (by discretion of study physician), including:
Inflammatory bowel disease (IBD) including ulcerative colitis (mild-moderate-severe), Crohn s disease (mild-moderate-severe), orindeterminate colitis;
Irritable bowel syndrome (IBS) (moderate-severe);
Persistent, infectious gastroenteritis, colitis or gastritis, persistent orchronic diarrhea of unknown etiology, Clostridium difficile infection (recurrent) or Helicobacter pylori infection (untreated);
Chronic constipation
Consumes more than 3 alcoholic beverages per day
Currently receiving or has received antibiotics, antifungals, antivirals, orantiparasitics in past 2 months
Is currently using or has used probiotic supplements within the last 2 months
Is currently on a weight-loss program or has experienced a weight change (gain orloss) of greater than 15 pounds in the past 3 months
Has a history of hospitalization for mental health condition and/or has had a changein depression or anxiety prescription medications within the past 10 weeks (bydiscretion of study physician)
Is pregnant or breastfeeding or planning pregnancy within the time of the study
Subjects who are not fluent in English
Use of smoking or chewing tobacco, e-cigarettes, cigars, or othernicotine-containing products, or cannabis
Regular use of prescription opiate pain medication
Weight <100 lbs
Acute disease, defined as the presence of a moderate or severe illness with orwithout fever, at the time of enrollment
Inability to communicate effectively with study personnel
Lack of commitment with the intervention or non-compliance (at the discretion of theinvestigator)
Eating disorders
Study Design
Study Description
Connect with a study center
National Institutes of Health Clinical Center
Bethesda, Maryland 20892
United StatesSite Not Available
National Institutes of Health Clinical Center
Bethesda 4348599, Maryland 4361885 20892
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.